Search Results

There are 2426 results for: content related to: Expert Review on Poliovirus Immunity and Transmission

  1. Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs

    Risk Analysis

    Volume 33, Issue 4, April 2013, Pages: 606–646, Radboud J. Duintjer Tebbens, Mark A. Pallansch, Konstantin M. Chumakov, Neal A. Halsey, Tapani Hovi, Philip D. Minor, John F. Modlin, Peter A. Patriarca, Roland W. Sutter, Peter F. Wright, Steven G.F. Wassilak, Stephen L. Cochi, Jong-Hoon Kim and Kimberly M. Thompson

    Version of Record online : 28 MAR 2013, DOI: 10.1111/risa.12031

  2. Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses

    Risk Analysis

    Volume 33, Issue 4, April 2013, Pages: 703–749, Radboud J. Duintjer Tebbens, Mark A. Pallansch, Dominika A. Kalkowska, Steven G. F. Wassilak, Stephen L. Cochi and Kimberly M. Thompson

    Version of Record online : 22 MAR 2013, DOI: 10.1111/risa.12044

  3. Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses

    Risk Analysis

    Volume 33, Issue 4, April 2013, Pages: 647–663, Kimberly M. Thompson, Mark A. Pallansch, Radboud J. Duintjer Tebbens, Steve G. Wassilak and Stephen L. Cochi

    Version of Record online : 17 SEP 2012, DOI: 10.1111/j.1539-6924.2012.01891.x

  4. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 7, July 2014, Pages: 912–926, Punna Rao Ravi, Rahul Vats, Vikas Dalal and Aditya Narasimha Murthy

    Version of Record online : 18 FEB 2014, DOI: 10.1111/jphp.12217

  5. You have free access to this content
    Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age

    Intervention Review

    The Cochrane Library

    Martina Penazzato, Andrew J. Prendergast, Lulu M Muhe, Denis Tindyebwa and Elaine Abrams

    Published Online : 22 MAY 2014, DOI: 10.1002/14651858.CD004772.pub4

  6. Robust fault detection based on adaptive threshold generation using interval LPV observers

    International Journal of Adaptive Control and Signal Processing

    Volume 26, Issue 3, March 2012, Pages: 258–283, Saúl Montes de Oca, Vicenç Puig and Joaquim Blesa

    Version of Record online : 5 JUL 2011, DOI: 10.1002/acs.1263

  7. Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase

    Journal of Cellular Biochemistry

    Volume 105, Issue 3, 15 October 2008, Pages: 814–823, Ly Q. Hong-Brown, C. Randell Brown, Danuta S. Huber and Charles H. Lang

    Version of Record online : 19 AUG 2008, DOI: 10.1002/jcb.21882

  8. You have free access to this content
    Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy

    HIV Medicine

    Volume 12, Issue 3, March 2011, Pages: 166–173, JS Lambert, LJ Else, V Jackson, J Breiden, S Gibbons, L Dickinson, DJ Back, M Brennan, EO Connor, N Boyle, C Fleming, S Coulter-Smith and SH Khoo

    Version of Record online : 18 AUG 2010, DOI: 10.1111/j.1468-1293.2010.00865.x

  9. Line profile variations in rapidly oscillating Ap stars: resolution of the enigma

    Monthly Notices of the Royal Astronomical Society

    Volume 376, Issue 2, April 2007, Pages: 651–672, O. Kochukhov, T. Ryabchikova, W. W. Weiss, J. D. Landstreet and D. Lyashko

    Version of Record online : 16 FEB 2007, DOI: 10.1111/j.1365-2966.2007.11449.x

  10. You have free access to this content
    Lopinavir protein binding in HIV-1-infected pregnant women

    HIV Medicine

    Volume 11, Issue 4, April 2010, Pages: 232–238, FT Aweeka, A Stek, BM Best, C Hu, D Holland, A Hermes, SK Burchett, J Read, M Mirochnick, EV Capparelli and the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol Team

    Version of Record online : 3 DEC 2009, DOI: 10.1111/j.1468-1293.2009.00767.x

  11. You have free access to this content
    Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free Hospital

    HIV Medicine

    Volume 8, Issue 1, January 2007, Pages: 55–63, CJ Smith, AN Phillips, MS Youle, CA Sabin, FC Lampe, R Tsintas, M Tyrer and MA Johnson

    Version of Record online : 15 JAN 2007, DOI: 10.1111/j.1468-1293.2007.00431.x

  12. You have free access to this content
    Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial

    HIV Medicine

    Volume 14, Issue 1, January 2013, Pages: 49–59, C Orkin, E DeJesus, H Khanlou, A Stoehr, K Supparatpinyo, E Lathouwers, E Lefebvre, M Opsomer, T Van de Casteele and F Tomaka

    Version of Record online : 23 OCT 2012, DOI: 10.1111/j.1468-1293.2012.01060.x

  13. The LPV Motif Is Essential for the Efficient Export of Secretory DMP1 From the Endoplasmic Reticulum

    Journal of Cellular Physiology

    Volume 231, Issue 7, July 2016, Pages: 1468–1475, Tian Liang, Tian Meng, Suzhen Wang, Chunlin Qin and Yongbo Lu

    Version of Record online : 14 DEC 2015, DOI: 10.1002/jcp.25265

  14. Effect of Grapefruit Juice and Ritonavir on Pharmacokinetics of Lopinavir in Wistar Rats

    Phytotherapy Research

    Volume 26, Issue 10, October 2012, Pages: 1490–1495, P. R. Ravi, R. Vats, R. Thakur, S. Srivani and N. Aditya

    Version of Record online : 4 FEB 2012, DOI: 10.1002/ptr.4593

  15. You have full text access to this OnlineOpen article
    Model-Based Analysis of Unbound Lopinavir Pharmacokinetics in HIV-Infected Pregnant Women Supports Standard Dosing in the Third Trimester

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 5, Issue 3, March 2016, Pages: 147–157, J Chen, S Malone, HMA Prince, KB Patterson and JB Dumond

    Version of Record online : 22 MAR 2016, DOI: 10.1002/psp4.12065

  16. Lopinavir/Ritonavir Pharmacokinetic Profile: Impact of Sex and Other Covariates Following a Change From Twice-Daily to Once-Daily Therapy

    The Journal of Clinical Pharmacology

    Volume 47, Issue 8, August 2007, Pages: 970–977, Dr. Ighovwerha Ofotokun, Dr. Susan K. Chuck, Dr. Jose N. Binongo, Mr. Mauricio Palau, Dr. Jeffrey L. Lennox and Dr. Edward P. Acosta

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007302564

  17. Coadministration With Lopinavir and Ritonavir Decreases Exposure to BILR 355, a Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 7, July 2011, Pages: 1061–1070, Fenglei Huang, Paul Scholl, David B. Huang, Thomas R. MacGregor, Richard Vinisko, Mark A. Castles, Frank Berger and Patrick Robinson

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010376971

  18. You have free access to this content
    Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial

    HIV Medicine

    Volume 10, Issue 10, November 2009, Pages: 620–626, A Hill, A-G Marcelin and V Calvez

    Version of Record online : 6 JUL 2009, DOI: 10.1111/j.1468-1293.2009.00734.x

  19. Assessment of Lopinavir Pharmacokinetics With Respect to Developmental Changes in Infants and the Impact on Weight Band–Based Dosing

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 243–249, M Nikanjam, E G Chadwick, B Robbins, C Alvero, P Palumbo, R Yogev, J Pinto, R Hazra, M L Hughes, B E Heckman, E V Capparelli and IMPAACT P1030 Team

    Version of Record online : 21 DEC 2011, DOI: 10.1038/clpt.2011.218

  20. Linear models-based LPV modelling and control for wind turbines

    Wind Energy

    Volume 18, Issue 7, July 2015, Pages: 1151–1168, A. Díaz de Corcuera, A. Pujana-Arrese, J. M. Ezquerra, A. Milo and J. Landaluze

    Version of Record online : 23 APR 2014, DOI: 10.1002/we.1751